<DOC>
	<DOCNO>NCT00821210</DOCNO>
	<brief_summary>Specific Aim 1 . To determine prevalence OSA patient first-time AMI acute phase By screen patient first-time , single-vessel disease , Killip I AMI , successful revascularization 2 . To determine impact CPAP treatment prognosis AMI Using sham CPAP optimal placebo , conduct randomize , double-blind , placebo control trial ass 12-week CPAP effect moderate-severe OSA patient . 3 . To determine OSA affect patient MI acute chronic phase vice versa , dissect mechanical basis molecular basis By compare clinical parameter AMI patient without OSA ( AHI &lt; 5/hr ) , mild OSA ( 5 &lt; AHI &lt; 15 ) , moderate OSA ( 15 &lt; AHI &lt; 30 ) severe OSA5 ( AHI &gt; 30/hr ) , CPAP treatment , determine interaction OSA AMI .</brief_summary>
	<brief_title>Obstructive Sleep Apnea Acute Myocardial Infarction Role Continuous Positive Airway Pressure ( CPAP ) Treatment</brief_title>
	<detailed_description>Obstructive sleep apnea ( OSA ) major public health problem affect least 2-4 % middle-aged population . OSA result hypoxia sleep fragmentation , result neurocognitive dysfunction cardiovascular sequelaes . The cardiovascular sequelaes OSA include hypertension , coronary artery disease heart failure . Our data show among 599 moderate-sever OSA ( AHI &lt; 15/hr ) ， 44.5 % patient cardiovascular disease , include 41.4 % hypertension，7 % CAD 2.4 % congestive heart failure。 Though OSA well know highly correlated fatal non-fatal cardiac event , limited study investigate OSA affect acute myocardial infarction ( AMI ) . Most study conclude AMI would worsen OSA vice versa . However , AMI exactly interact OSA prevalence OSA first-time AMI never answer . Within four week Nov. 15th 2007 , screen ten patient first-time AMI single-vessel disease Killip I . Five 10 receive PSG three five moderate OSA . So far , CPAP standard treatment patient moderate severe OSA . CPAP could improve airway patency , daytime sleepiness , functional status , blood pressure , metabolic abnormality quality life . In study , enrol 24 non-sleepy OSA 30 sleepy OSA study four-week CPAP effect . The result show apnea-hypopnea index , hypoxia , arousal , sleepiness fatigue could correct CPAP treatment group . However , CPAP could lower risk factor cardiovascular disease , like blood pressure , epinephrine , norepinephrine CRP , sleepy OSA . Our find support CPAP effect similar subgroup severe OSA , CPAP effect study every subgroup OSA patient 's apply . Till , 's literature report CPAP treatment would decrease morbidity mortality AMI . Sham CPAP mimic characteristic true CPAP except null pressure , recently use placebo study CPAP effect . Therefore , use optimize placebo , propose double-blind , control randomize trial ( 1 ) To determine prevalence OSA patient first-time AMI acute phase ; ( 2 ) To determine impact CPAP treatment prognosis AMI ; ( 3 ) Determine OSA affect patient MI acute chronic phase vice versa , dissect mechanical basis molecular basis .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>1 . Firsttime AMI 2. s/p revascularization ( successful primary PTCA ischemiarelated artery ) 3 . Killip I 1 . Refuse participate 2 . Require mechanical ventilation 3 . Having active neurologic event , severe obstructive airway disease active infection , active malignancy 4 . Need sedative drug narcotic study period within 3 day PSG 5 . Participates study time</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Obstructive sleep apnea</keyword>
	<keyword>myocardial infarction</keyword>
</DOC>